Medical Oncologist
CION Cancer Clinics
Y-90 for liver metastases: bowel, neuroendocrine and other cancers | CION Cancer Clinics
Y-90 can treat cancer that has spread to the liver when the liver is where most of the cancer sits. It is used most for bowel cancer after chemotherapy stops working, and for neuroendocrine tumours. It treats the liver only, so it usually sits beside medicines rather than replacing them. This page explains who it suits, what happens and when it is not the right choice. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can Y-90 treat cancer that has spread to the liver?
- Which cancers spreading to the liver is Y-90 used for?
- What happens if Y-90 is suggested for liver metastases?
- What do the words in the Y-90 discussion mean?
- What do families often get wrong about Y-90 for spread?
- Who is Y-90 not right for?
- What this page cannot tell you
- Common questions about Y-90 for liver metastases
The short answer
Can Y-90 treat cancer that has spread to the liver?
Yes, for some people. Y-90 radioembolisation can treat cancer that has spread to the liver from another organ, most often the bowel or a neuroendocrine tumour, when the liver is where most of the cancer sits. It is a liver-directed treatment that usually sits alongside chemotherapy or other medicines, not in place of them.
Which liver cancer this page is about
This page is about secondary liver cancer, also called liver metastases. The cancer started somewhere else and travelled to the liver, so it is still treated as that original cancer. If your doctor has said hepatocellular carcinoma (HCC), the cancer started in the liver itself, and our page on Y-90 as a bridge or the Y-90 explainer fits you better. If you are unsure which you have, read what liver metastases on a report means.
What Y-90 actually does
Tiny beads carrying radiation are passed through a thin tube into the liver artery. They lodge in the small vessels feeding the tumours and give radiation from close range, while most of the healthy liver, which takes its blood mainly from the portal vein, is spared.
Y-90 treats the liver only. It does nothing for cancer in the lungs, bones or elsewhere.By cancer type
Which cancers spreading to the liver is Y-90 used for?
The original cancer decides the plan. Y-90 means something different for each of these.
Bowel (colorectal) cancer
Usually considered when the cancer is mainly in the liver and chemotherapy has stopped working or cannot continue. Studies that added Y-90 to the first chemotherapy did not show a clear benefit for most people, so it is rarely the first step. Surgery, ablation and chemotherapy come first. The full picture sits on colon cancer spread to the liver.
Neuroendocrine tumours
These often grow slowly and can fill the liver while staying elsewhere small. Y-90 is one of several liver treatments, alongside embolisation and medicines. It can also ease flushing or diarrhoea caused by hormones the tumours release.
Other options the team may weigh
- Surgery, if the spots can be removed
- Bland embolisation or TACE
- Lu-177 DOTATATE for the whole body
Other cancers
Breast cancer, a melanoma of the eye and a few others sometimes spread mainly to the liver. Y-90 is used in selected cases, and the evidence is thinner. Our page on rare spread to the liver covers these.
The common thread
In every case the liver must be the main problem, the liver must still work well enough, and the cancer elsewhere must be absent or under control.
Not sure whether this applies to you?
Ask an oncologistThe path
What happens if Y-90 is suggested for liver metastases?
Tumour board review
Your oncologist presents the scans, the original cancer's history and what treatment you have already had. The board asks whether a liver treatment adds anything to your medicines.
Scans of the whole body
A CT or PET-CT checks that the cancer is mainly in the liver. CION arranges these through diagnostic partners.
The mapping scan
At a partner hospital, an interventional radiologist maps the liver arteries and measures how much radiation would reach the lungs. This can rule Y-90 out. See the mapping scan.
The treatment
CION coordinates the Y-90 procedure through accredited partner hospitals licensed to handle the radioactive beads. Chemotherapy may pause around it.
Back to your oncologist
Scans after treatment show how the liver tumours responded. Your medical oncologist then plans the next medicines or follow-up.
On your report
What do the words in the Y-90 discussion mean?
- Liver-dominant disease
- Most of the cancer is in the liver, with little or none elsewhere. This is the situation where Y-90 is considered.
- Salvage treatment
- A treatment used after the standard ones have stopped working. For bowel cancer, Y-90 is usually used in this setting.
- Lung shunt
- The share of beads that would slip past the liver into the lungs. Too much makes Y-90 unsafe. See lung shunting.
- Liver-directed therapy
- Any treatment aimed only at the liver: surgery, ablation, TACE, Y-90 or focused radiation.
- Systemic therapy
- Medicines that travel through the whole body, such as chemotherapy, targeted therapy or immunotherapy.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about Y-90 for spread?
"Once it is in the liver, it has become liver cancer."
It stays the original cancer. Bowel cancer in the liver is still bowel cancer and is treated with bowel cancer medicines. This is why your medical oncologist leads the plan, not only the liver team.
"Y-90 can replace chemotherapy."
It treats only the liver. Cancer cells elsewhere in the body need medicines that travel in the blood. Y-90 is added to that plan or used when medicines run out, not instead of them.
"Newer and costlier means stronger."
For bowel cancer spread, Y-90 has not been shown to beat good chemotherapy as a first step. Surgery or ablation, where possible, remain the options with curative intent. Y-90 has a place, but a specific one.
"If the doctor did not offer it, they are holding back."
Often Y-90 simply does not fit: spread outside the liver, weak liver function, or a failed mapping scan. Asking why is reasonable, and a second opinion from a tumour board is a fair request.
Being honest
Who is Y-90 not right for?
Y-90 is usually not offered when the cancer is growing in several places outside the liver, because treating the liver alone will not change the course of the illness. It is not offered when the liver is already failing, with jaundice or fluid in the abdomen (ascites), or when the mapping scan shows too much leaking to the lungs or the stomach.
When something simpler fits
If the liver spots can be removed or burned, surgery or ablation usually comes first. If you are too unwell to travel or to recover from a procedure, comfort and symptom care may serve you better than another treatment.
When access is the barrier
Y-90 is available only in some Indian cities and the cost is quoted separately by the centre that does it. Ask for a written, itemised estimate that includes the mapping scan, and check scheme or insurance cover before you commit.
Being straight with you
What this page cannot tell you
It cannot tell you whether Y-90 suits your liver spots, or what it will achieve. That depends on the original cancer, the treatment you have already had, how much of the liver is involved and how well it works. The evidence is strongest for some situations and thin for others, and a fair discussion will say which applies to you.
Who can answer it
Your medical oncologist, together with an interventional radiologist and the tumour board. At CION, medical oncologists lead the review and coordinate the mapping scan and Y-90 through partner hospitals.
Bring your original diagnosis report, the list of treatments you have had, and your latest scans. That is what the board needs to give you a real answer.Questions we are asked
Common questions about Y-90 for liver metastases
Is Y-90 used for bowel cancer that has spread to the liver?
Yes, mostly when the cancer is mainly in the liver and chemotherapy has stopped working or cannot continue. It is not usually the first treatment. Surgery or ablation, if possible, and chemotherapy come before it. Your medical oncologist decides where it fits in your plan.
Does Y-90 work for neuroendocrine tumours in the liver?
It is one of several liver treatments for these tumours and can also ease hormone symptoms such as flushing. The choice between Y-90, embolisation, Lu-177 DOTATATE and medicines depends on the tumour grade and where else it has spread. A tumour board weighs these together.
Can I keep having chemotherapy with Y-90?
Often yes, though some medicines may be paused around the procedure to protect the liver. Your medical oncologist and the interventional radiologist agree the timing between them. Never stop or restart medicines on your own around a Y-90 treatment.
Will Y-90 remove the cancer for good?
Usually not. For most people with liver metastases, Y-90 aims to control the liver tumours and ease symptoms. Occasionally it shrinks tumours enough for surgery to be reconsidered. Your team will be honest about which aim applies to you.
Does CION do Y-90 itself?
No. CION's oncologists assess you, present your case at the tumour board and manage your medicines. The mapping scan and the Y-90 procedure are coordinated through accredited partner hospitals with interventional radiology and a licence for radioactive treatment.
What side effects should I expect?
Tiredness, mild abdominal discomfort, nausea and a low fever for a short while are common. Rarer problems include liver strain or a stomach ulcer if beads go astray. Our page on side effects of Y-90 explains what to watch for.
Is it safe to be near family after Y-90?
The radiation stays inside the liver and fades steadily. You will be given simple precautions, especially around pregnant women and small children, for a short period. Follow the written advice from the treating hospital, which is the authority on this.
How do I get my case reviewed?
Call the CION helpline and ask for a tumour board review. Keep the original biopsy report, a list of every treatment and your latest scans ready. If you are travelling from a district, the team can tell you which reports to send first.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- RadiologyInfo.org (RSNA/ACR) — Radioembolization (Y90)
- National Cancer Institute — Metastatic Cancer: When Cancer Spreads
- NHS — Neuroendocrine cancers
- American Cancer Society — Embolization Therapy for Liver Cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Secondary liver cancer: what it meansStart here if the word metastases is newNeuroendocrine tumours in the liverThe full set of options for this tumour typeWho is suitable for Y-90?The checks that decide whether Y-90 is safeColon cancer spread to the liverWhere bowel cancer liver spread is covered in full
Talk to us
Could Y-90 help with the spots in my liver?
Send your original diagnosis, your treatment history and your latest scans, and the tumour board will review whether a liver-directed treatment adds anything to your plan. We will tell you plainly if it does not. One helpline serves every CION centre.